product summary
company name :
BD Biosciences
other brands :
Transduction Laboratories, PharMingen, Difco
product type :
antibody
product name :
CD38
catalog :
560982
quantity :
25 Tests
price :
85.00 USD
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
HIT2
The same clone is also sold as:
The same clone is also sold as:
- Abnova: MAB12225, MAB3836, MAB5072
- LifeSpan Biosciences: LS-C105947, LS-C46310, LS-C127553, LS-C46396, LS-C107248, LS-C107368, LS-C414502, LS-C202106, LS-C202105, LS-C46504, LS-C106059, LS-C112582, LS-C202104, LS-B4500, LS-C127554, LS-B3774, LS-C106546, LS-C106820, LS-B1955, LS-C46224, LS-C204952
- BioLegend: 303516, 303532, 303535, 303528, 303521, 980302, 303520, 303507, 303527, 303531, 303526, 303523, 303534, 303511, 303522, 303514, 303537, 303533, 303505, 303519, 303502, 303524, 303525, 303509, 303530, 303506, 303508, 303529, 303510, 303539, 303515, 303538, 303503, 303504, 303518, 303540, 980304, 303512
- Invitrogen: MHCD3801-4, 47-0389-42, 17-0389-41, 25-0389-42, MHCD3819, 48-0389-42, 47-0389-41, 13-0389-82, 48-0389-41, MHCD3801, MA1-19316, MA5-16705, MHCD3805, 11-0389-41, 15-0389-42, MA1-10215, 12-0389-41, MHCD3817, Q22150, 61-0389-42, 17-0389-42, MHCD3804, 12-0389-42, 56-0389-41, 61-0389-41, 11-0389-42, MA1-19773, 25-0389-41, 56-0389-42, MA1-19523, 14-0389-82
- Bio-Rad: MCA1718F, MCA1718PE, MCA1718C, MCA1718GA
reactivity :
human
application :
immunocytochemistry, flow cytometry
more info or order :
citations: 3
Published Application/Species/Sample/Dilution | Reference |
---|---|
| Fatehchand K, McMichael E, Reader B, Fang H, Santhanam R, Gautam S, et al. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells. J Biol Chem. 2016;291:25656-25666 pubmed
|
| |
product information
Cat.# :
560982
Brand :
BD Pharmingen
Name :
CD38
Format :
FITC
Clone :
HIT2
Isotype :
Ms IgG 1
React :
Hu
Apps :
FCM
Size :
25 Tests
Status :
RUO
List Price :
85.00 USD
more info or order :
company information
BD Biosciences
review
product type
related products
questions and comments